Abstract. The present study was undertaken to investi-
gate the release of thyroid hormones from cultured thyroid slices of untreated patients with Graves' disease in response to autologous IgG and IgG from other untreated patients with Graves' disease. Thyroid tissue (8\p=n-\10mg) was obtained by needle biopsy from 11 untreated patients with Graves' disease, and each biopsy was divided into 5 slices. Slices were then cultured in Ham's F-12 synthetic media for 7 days with IgG (1.3 mg/ml) obtained from the same patients, IgG obtained from other untreated patients, normal IgG, or bovine TSH (1.3 mIU/ml). Media were changed every day, and the concentrations of triiodothyronine (T3) in the media were measured by radioimmunoassay (RIA) , and the concentrations of thyroidal cAMP were measured by radioimmunoassay on the last day of culture after incubation with 10 mm theophylline at 37\s=deg\Cfor 30 min. When thyroid slices were incubated with autologous IgG, the release of T3 increased from the 3rd day, and the increase was 3-to 10-fold above controls on the 5th day, and the production of thyroidal cAMP significantly increased 2-to 3-fold. However, when slices were incubated with IgG obtained from other untreated patients, the concentration of T3 in media and the production of thyroidal cAMP did not differ from that in controls. TSH increased the release of T3 from thyroid slices 2. 5\ x=req-\ to 10-fold above controls on the 5th day and the production of cAMP 4-to 5-fold. These results strongly suggest that thyroid hormone releasing IgG in patients with Graves' disease are highly specific for autologous thyroids. The mechanism of this specificity may involve the role of self-recognition, such as antiidiotype antibody or anti-major histocompatibility complex antibody.
It has been reported from many laboratories that Graves' IgG inhibits the binding of TSH to thy¬ roid plasma membrane and stimulates thyroidal adenylate cyclase activity (Burman & Baker 1985 (Nagataki 1982; Hamada et al. 1983 ). However, in spite of a significant increase in thyroidal cAMP concentra¬ tions, the release of thyroid hormones from nor¬ mal thyroid tissues was not stimulated by Graves' IgG (Nagataki 1982 Organ culture ofthyroid slices Thyroid tissue (8-10 mg) was obtained by Silverman needle biopsy. Tissue from each patient was divided into 5 slices and weighed, and slices were then cultured for 7 days in the organ culture system developed in our laboratory, details of which were previously reported (Hamada et al. 1983) .
Several thyroid stimulators were tested in this organ culture system: 1) IgG (1.3 mg/ml) obtained from the same Graves' patient, 2) IgG obtained from other un¬ treated patients, 3) normal IgG or 4) bovine TSH (Sigma 1.3 mIU/ml), was added to slices from the first day of culture. IgG were absorbed by protein A-Sepharose 4B columns, eluted with 0.1 M glycine buffer pH 2.5, dialysed with phosphate buffer pH 7.4 and concen¬ trated to 10 mg/ml protein by an Amicon concentrator.
In order to determine the concentrations of T3 in the culture media, media were changed daily, and the concentrations of T3 were measured by RIA and ex¬ pressed as the concentration in the media divided by wet weight of thyroid slices.
The concentrations of thyroidal cAMP were meas¬ ured by RIA on the last day of culture after incubation with 10 mM theophylline at 37°C for 30 min.
Results
Fig . 1 (Fig. 2) . However, the increase of cAMP by autologous IgG was less than 2-fold.
As shown in Fig. 3 (1974) reported that serum concentration of 131I increased in response to daily infusions of pooled Graves' sera in 5 normal subjects who had received 131I and had been given 75 µg T3 daily. The discrepancy be¬ tween their results and ours is not clear, however, they injected pooled sera obtained from many patients into normal subjects, while individual sera from Graves' patients were tested in vitro in the present study.
In contrast to the response in normal thyroid slices, autologous IgG stimulated both the pro¬ duction of cAMP and the release of T3 in thyroid slices from untreated patients with Graves' dis¬ ease, but neither the production of cAMP nor the release of T3 was stimulated by IgG obtained from other untreated patients with Graves' disease. As reported previously (Kuzuya et (Searles et al. 1983 ) and systemic lupus erythematosus (Okudaira et al. 1982) (Islam et al. 1983; Burman & Baker 1985) .
We must consider not only the heterogenity of Graves' IgG but also the abnormality of Graves' thyroid including thyroidal lymphocytes and clar¬ ify the characteristics of those lymphocytes.
Susceptibility for Graves' disease was reported earlier to be controlled by immunoregulatory genetic haplotypes of HLA and Gm (Nagataki 1982; Tamai et al. 1985) . In our present study an exceptional IgG obtained from one of the patients stimulated untreated allogeneic thyroid slices. This patient may have had the same immunore¬ gulatory genes of susceptibility as the donor pa¬ tient of the thyroid slices which were used.
